(Q39462060)

12 September 2017

Failure of basic protein therapy for multiple sclerosis (English)

1 reference

12 September 2017

0 references

R E Gonsette

1

1 reference

PubMed ID

72790

12 September 2017

P Delmotte

series ordinal

2

1 reference

PubMed ID

72790

12 September 2017

L Demonty

series ordinal

3

1 reference

12 September 2017

1 August 1977

1 reference

12 September 2017

1 reference

12 September 2017

216

1 reference

12 September 2017

1

1 reference

12 September 2017

27-31

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00312812

12 September 2017

0 references

cites work

Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders

1 reference

12 December 2020

Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response

1 reference

12 December 2020

Prevention of experimental allergic encephalomyelitis by nonencephalitogenic basic peptides

1 reference

12 December 2020

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

1 reference

12 December 2020

Intensive immunosuppression in the treatment of multiple sclerosis.

1 reference

12 December 2020

Myelin basic protein administration in multiple sclerosis

1 reference

12 December 2020

Biochemical findings in multiple sclerosis. V. Transformation of lymphocytes from patients with multiple sclerosis by human basic protein

1 reference

12 December 2020

Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein

1 reference

12 December 2020

Cyclophosphamide inhibition of experimental allergic encephalomyelitis and cellular transfer of the disease in Lewis rats

1 reference

12 December 2020

Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years

1 reference

12 December 2020

Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone

1 reference

12 December 2020

Protection against experimental allergic encephalomyelitis.

1 reference

12 December 2020

Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

12 December 2020

Critique of experimental trials of therapy in multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00312812

1 reference

12 September 2017

1 reference

PubMed ID

72790